Market Vectors Pharmaceutical ETF (PPH)

Add to Watchlists
Create an Alert
65.23 +1.15  +1.79% NYSE Arca Nov 21, 8:00PM BATS Real time Currency in USD
View Full Chart
PPH Price Chart

PPH Description

Market Vectors Pharmaceutical ETF is a long only equity fund managed by Market Vectors that tracks the MV US Listed Pharmaceutical 25 NR USD index and has 361.38M USD assets under management. It has an expected distribution yield of 1.58%, a Forecasted PE Ratio of 22.20, and a Forecasted Price to Book Value of 3.629. The fund has a net expense ratio of 0.35%, turns over its positions 3.00% per year, and is traded on the New York Stock Exchange Arca.

PPH Key Info

Expense Ratio (2-1-14) 0.35%
Assets Under Management (11-21-14) 361.38M
30-Day Average Volume (11-21-14) 115523.3
Net Asset Value (11-21-14) 65.25
Discount or Premium to NAV (11-21-14) -0.03%
Turnover Ratio (9-30-13) 3.00%

PPH Asset Allocation

Type % Net % Long % Short
Cash -0.00% 0.00% 0.00%
Stock 100.4% 100.4% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other -0.39% 0.00% 0.39%
As of Nov. 20, 2014

PPH Region Exposure

Americas 64.93%
North America 64.93%
Latin America 0.00%
Greater Europe 35.07%
United Kingdom 12.24%
Europe Developed 19.09%
Europe Emerging 0.00%
Africa/Middle East 3.74%
Greater Asia 0.00%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00%
As of Nov. 13, 2014
Region breakdown data is calculated by using the long position holdings of the portfolio.

PPH Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 100.0%
Industrials 0.00%
Real Estate 0.00%
Technology 0.00%
Utilities 0.00%
As of Nov. 20, 2014

PPH Stock Market Capitalization

Giant 76.93%
Large 21.27%
Medium 2.19%
Small 0.00%
Micro 0.00%
As of Nov. 20, 2014
View More Holdings

PPH Top 10 Holdings

Name % Weight Price Chg %
Johnson & Johnson 11.01% 107.86 -0.30%
Novartis AG ADR 9.93% 94.98 -0.30%
Pfizer Inc 7.36% 30.45 +0.03%
Merck & Co Inc 5.69% 59.66 +0.47%
Bristol-Myers Squibb Company 5.02% 58.80 +0.32%
AbbVie Inc 4.99% 67.36 +3.33%
Actavis PLC 4.78% 259.75 +0.49%
GlaxoSmithKline PLC ADR 4.77% 46.40 +0.04%
Novo Nordisk A/S ADR 4.69% 44.29 -0.14%
Allergan Inc 4.63% 209.09 -0.53%
As of Nov. 20, 2014
Get Quote for
Advertisement

PPH Basic Info

Style
Asset Class Sector Equity
Prospectus Objective Specialty - Health
Fund Owner Firm Name Market Vectors
Benchmark Index
MV US Listed Pharmaceutical 25 NR USD 100.0%
Key Dates
Inception Date 12/20/2011
Last Annual Report Date 9/30/2013
Last Prospectus Date 2/1/2014
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available RRSP No

PPH Manager Info

Name Tenure
George Cao 2.87 yrs
Hao-Hung (Peter) Liao 2.87 yrs

PPH Risk Info

Beta --
30 Day Average Volatility 16.11%

PPH Fundamentals

Dividend Yield TTM (11-21-14) 1.58%
Weighted Average PE Ratio 25.99
Weighted Average Price to Sales Ratio 2.887
Weighted Average Price to Book Ratio 4.122
Weighted Median ROE 23.64%
Weighted Median ROA 9.20%
Forecasted Dividend Yield 2.23%
Forecasted PE Ratio 22.20
Forecasted Price to Sales Ratio 2.989
Forecasted Price to Book Ratio 3.629
Number of Holdings 25.00
As of Nov. 20, 2014

PPH Growth Estimates

Forecasted 5 Yr Earnings Growth 8.00%
Forecasted Book Value Growth 6.30%
Forecasted Cash Flow Growth -1.94%
Forecasted Earnings Growth -0.73%
Forecasted Revenue Growth 2.66%
As of Nov. 20, 2014

PPH Performance

  Returns Total Returns
1M 7.34% 7.34%
3M 6.05% 6.38%
6M 9.56% 10.36%
1Y 25.85% 28.07%
3Y -- --
5Y -- --
As of Nov. 21, 2014

PPH Flows

1M -18.65M
3M 88.04M
6M 21.19M
YTD 64.17M
1Y 69.18M
3Y --
5Y --
As of Oct. 31, 2014
Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.